MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced today that it has been added to the NASDAQ® NeuroInsights® Neurotech Index (NASDAQ:NERV). The Neurotech Index is designed to track the performance of leading neurotechnology companies listed and actively traded on one of the three major U.S. stock exchanges.
